Industry Briefs: June 11, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Adventrx Pharmaceuticals and Pierre Fabre Medicament have entered into a manufacturing agreement for ANX-188 drug substance.
Almac and VTU Technology have formed a collaboration for joint-services for site-specification modification and labeling, such as PEGylation.
Analytical Solutions has changed its name to Tergus Pharma to reflect its expanded services in dermatology product development.
Anderson Packaging and Brecon Pharmaceuticals have announced plans to realign the companies’ businesses to form a full-service pharmaceutical packaging company, under the name AndersonBrecon.
Michael Valazza, vice-president in Catalent’s Modified Release Technologies business will conduct a workshop on “Coordination of Activities and Responsibilities for Solid Dosage Forms” at the Pharmaceutical Technology Transfer Course being held in Amsterdam, the Netherlands on June 13–14, 2012.
Cobra Biologics and Alligator Bioscience have announced that they have entered into a manufacturing services and supply agreement for the production of a monoclonal antibody drug substance and product for preclinical studies and Phase I–II clinical trials.
GlaxoSmithKline has successfully used Capsugel’s Licaps liquid-filled hard capsules for Granu Fink, a product line in the German urological market.
The Johnson & Johnson subsidiary Animas has announced positive results from the first human clinical trials of a first-generation artificial pancreas system for treating Type I diabetes.
Maxxam Analytics has acquired Becquerel Laboratories.
MeadWestvaco has acquired the Aardex Group, a company that develops solutions to assess medication adherence by ambulatory patients.
Particle Sciences has expanded its cGMP capabilities with the addition of thin-film technology.
Protalix has received a $25-million milestone payment from Pfizer for the US approval of Elelyso (taliglucerase alfa).
Recipharm has invested in a Dara cartridge-filling machine for injectable solutions at its facility in Monts, Loire Valley, France. The machine features filling volumes between 1.5 and 5 mL, and can operate at speeds up to 7200 cartridges per hour.
SAFC will consolidate its global chiral chromatography screening and small-scale purification operations and locate them at its Pharmorphix solid-state research laboratories in Cambridge, United Kingdom, to support its new integrated chiral chemistry offering.
SGS has opened its cell-based assay laboratory at its facility in Poitiers, France.
Suzhou Pharma Services has announced its new US corporate offices in Lyndhurst, New Jersey, and its new FDA-approved manufacturing facility in Suzhou, China.
People News
Lachman Consultant Services has named David Jaworski as a director in its compliance practice.
SCM Pharma has appointed Paul Thomas as a director for its senior team.
USON has appointed Charles D. Foran Jr. as president.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
